A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants

NCT01866007 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Guselkumab (lyophilized formulation)
DRUG: Guselkumab (liquid formulation with PFS-U)
DRUG: Guselkumab (liquid formulation with PFS FID)
DRUG: Guselkumab (liquid formulation)

Sponsor

Janssen Research & Development, LLC